205 related articles for article (PubMed ID: 3390658)
1. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
Hill BT; Whelan RD
Cancer Chemother Pharmacol; 1982; 8(2):163-9. PubMed ID: 7105380
[TBL] [Abstract][Full Text] [Related]
3. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
Tolis C; Photiou A; Camplejohn RS; Retsas S
Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
[TBL] [Abstract][Full Text] [Related]
6. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H
Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
[TBL] [Abstract][Full Text] [Related]
7. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
Poppitt DG; McGown AT; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
[TBL] [Abstract][Full Text] [Related]
8. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
Iqbal Z; Ochs S
J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
[TBL] [Abstract][Full Text] [Related]
9. Vindesine: a new vinca alkaloid.
Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
[TBL] [Abstract][Full Text] [Related]
10. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.
Attaoua C; Vincent LA; Abdel Jaoued A; Hadj-Kaddour K; Baï Q; De Vos J; Vian L; Cuq P
Fundam Clin Pharmacol; 2015 Feb; 29(1):62-71. PubMed ID: 25283245
[TBL] [Abstract][Full Text] [Related]
12. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
13. Role of cell cholesterol in modulating vincristine uptake and resistance.
Pallarés-Trujillo J; Domènech C; Grau-Oliete MR; Rivera-Fillat MP
Int J Cancer; 1993 Oct; 55(4):667-71. PubMed ID: 8406997
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
Pereira E; Tarasiuk J; Garnier-Suillerot A
Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
[TBL] [Abstract][Full Text] [Related]
15. Block of axoplasmic transport in vitro by vinca alkaloids.
Chan SY; Worth R; Ochs S
J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
[TBL] [Abstract][Full Text] [Related]
16. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
Safa AR; Glover CJ; Felsted RL
Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
[TBL] [Abstract][Full Text] [Related]
17. Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.
Smeland E; Bremnes RM; Bessesen A; Jaeger R; Aarbakke J
Cancer Chemother Pharmacol; 1993; 32(3):209-14. PubMed ID: 8500226
[TBL] [Abstract][Full Text] [Related]
18. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells.
Tamai I; Safa AR
J Biol Chem; 1990 Sep; 265(27):16509-13. PubMed ID: 1975813
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines.
Photiou A; Sheikh MN; Bafaloukos D; Retsas S
J Cancer Res Clin Oncol; 1992; 118(4):249-54. PubMed ID: 1577845
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
Leonce S; Anstett M; Combe-Perez V; Pierre A
Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
